The inhibitor of DNA binding 2 (Id2) is essential for natural killer (NK) cell development with its canonical role being to antagonize E-protein function and alternate lineage fate. Here we have identified a key role for Id2 in regulating interleukin-15 (IL-15) receptor signaling and homeostasis of NK cells by repressing multiple E-protein target genes including Socs3. Id2 deletion in mature NK cells was incompatible with their homeostasis due to impaired IL-15 receptor signaling and metabolic function and this could be rescued by strong IL-15 receptor stimulation or genetic ablation of Socs3. During NK cell maturation, we observed an inverse correlation between E-protein target genes and Id2. These results shift the current paradigm on the role of ID2, indicating that it is required not only to antagonize E-proteins during NK cell commitment, but constantly required to titrate E-protein activity to regulate NK cell fitness and responsiveness to IL-15.
SUMMARY
The inhibitor of DNA binding 2 (Id2) is essential for natural killer (NK) cell development with its canonical role being to antagonize E-protein function and alternate lineage fate. Here we have identified a key role for Id2 in regulating interleukin-15 (IL-15) receptor signaling and homeostasis of NK cells by repressing multiple E-protein target genes including Socs3. Id2 deletion in mature NK cells was incompatible with their homeostasis due to impaired IL-15 receptor signaling and metabolic function and this could be rescued by strong IL-15 receptor stimulation or genetic ablation of Socs3. During NK cell maturation, we observed an inverse correlation between E-protein target genes and Id2. These results shift the current paradigm on the role of ID2, indicating that it is required not only to antagonize E-proteins during NK cell commitment, but constantly required to titrate E-protein activity to regulate NK cell fitness and responsiveness to IL-15.
INTRODUCTION
Natural killer (NK) cells are enriched in lymphoid organs and blood, and they have evolved a vast array of germline-encoded receptors that scan for abnormalities on our tissues, which has important implications for viral and tumor immunity (Huntington et al., 2007c) . The development of diverse lymphocyte types from hematopoietic progenitors is essential for effective broadspectrum immunity in mammals and requires the coordinated expression of multiple lineage-specific transcription factors. E-proteins are transcription factors encoded by the genes E2A (Tcf3), E2-2 (Tcf4), and HEB (Tcf12) and are required for T and B cell development. They contain a basic DNA-binding region and a helix-loop-helix (HLH) domain responsible for homo-dimerization and transcriptional activation, or hetero-dimerization with other (HLH) proteins that can either activate or repress gene transcription. Inhibitor of DNA-binding (Id) proteins also contain a HLH domain but lack a basic region and they prevent E-proteins from binding DNA through hetero-dimerization (reviewed in Murre, 2005) . The Id member Idb2 (referred to as Id2) plays an indispensible role in the development of NK cells (Boos et al., 2007; Yokota et al., 1999) . The canonical function of ID2 is to dimerize with E-proteins, thereby preventing E-protein from binding E-box (CANNTG)-containing target genes (Ephrussi et al., 1985; Henthorn et al., 1990; Murre et al., 1989 ). E-boxes are found in genes essential for T and B cell development, supporting their instructive role in B and T cell lineage development (reviewed in Quong et al., 2002) , but how the silencing of E-box genes promotes NK cell development remains unknown.
IL-15 is essential for NK cell survival by directly maintaining high expression of anti-apoptotic MCL1 while blocking the transcription of pro-apoptotic BIM (Bcl2l11) and NOXA (Pmaip1) (Huntington et al., 2007a; Sathe et al., 2014) . IL-15 mediates NK cell survival at lower IL-15 concentrations than that required for proliferation and activation (Huntington et al., 2007c) , and IL-15 signaling is achieved via phosphorylation of its receptor by JAK1 or JAK3, recruitment and phosphorylation of STAT5, and their translocation to the nucleus to activate STAT-responsive genes (Ma et al., 2006) . All ILCs and NK cells derive from ID2
+ progenitors (Klose and Diefenbach, 2014) , but the subsequent transcriptional events that establish dependency on IL-7 versus IL-15 are unknown. PLZF expression has been proposed to delineate ILC1-3 development from that of NK cells (legend continued on next page) (Constantinides et al., 2014) , and Nfil3 was recently suggested to function downstream of PLZF to drive ID2 + ILC progenitor development (Xu et al., 2015) , yet Nfil3 deficiency blocks the development of NK cells but not ILC1, indicating that it is unlikely to play a global role in regulating IL-15 and IL-7 dependency (Geiger et al., 2014; Seillet et al., 2014a Seillet et al., , 2014b . Furthermore, deletion of Nfil3 after ILC commitment using the Ncr1-icre (Nfil3 fl/fl Ncr1 icre/+ ) has no effect on NKp46 + NK cell, ILC1, or ILC3 homeostasis, indicating that Nfil3 is dispensable for cytokine signaling in these cell types (Firth et al., 2013; Geiger et al., 2014) .
Given the absence of NK cells in both Id2 À/À and Il15 À/À mice, we hypothesized that NK cell dependency on these two factors acts on a common pathway. We found that loss of Id2 in mature NK cells resulted in an upregulation of E-protein target genes, including Socs3 that contributed to IL-15 receptor hypo-responsiveness and culminated in impaired NK cell survival. Overcoming the consequences of elevated Socs3 expression by deletion of Socs3 or increasing the degree of IL-15 receptor ligation in vivo was sufficient to rescue the development of ID2-null NK cells. These findings reveal an unappreciated pathway in which the requirement for ID2, a key transcriptional regulator of lineage fate, is mediated at the level of homeostatic cytokine signaling. (Jackson et al., 2011) and multiple Cre-recombinase expressing strains to dissect the temporal requirement for ID2 in NK cell homeostasis. NK cells express abundant ID2 after commitment to the lineage Hoyler et al., 2012) and in all subsequent stages of development in all tissues examined (Figures 1A and 1B) . Consistent with the phenotype of Id2 À/À mice (Boos et al., 2007; Yokota et al., 1999) , Id2 fl/fl mice expressing Cre-recombinase in all hematopoietic cells (Vavcre, ERT2-cre + 4-OHT, and Mx-cre + pIpC) exhibited a significant block in NK cell development ( Figure 1C ). To overcome this developmental block, we inactivated Id2 specifically in NKp46 + cells using the Ncr1-icre (which deletes in NK cells at the immature CD11b À CD27 + stage) (Huntington et al., 2007b; Narni-Mancinelli et al., 2011; Sathe et al., 2014 (Figure 2A ). This approach was efficient with no Id2 being detected by qPCR ( Figure 2B ) and no ID2 protein being detected ( Figure 2C) Figure S1A ) and we confirmed that NK cell apoptosis at these limiting IL-15 concentrations was dependent on BIM ( Figure S1B ). Figure 2G ). Taken together, these data suggest that in vivo NK cell attrition after Id2 ablation is in part due to their inability to respond to homeostatic IL-15. Socs3, Cxcr5, Hes1, Idb3, Cd3g, Cd3d, Trgv2, Trvb15 , and Tcrg-C1 ( Figure 4 ). We did not detect alteration in the expression of genes known to play a role in NK cell development including Tox, Nfil3, Eomes, Il2rb, Il2rg, and Ets1 ( Figure 4C ), indicating that the role of Id2 in maintaining the NK cell lineage is independent of these factors. We confirmed the expression pattern of several of these genes by RT-PCR ( Figure S1D ) and noted that Socs3 and Tcf7 were consistently elevated after ID2 deletion in NK cells.
RESULTS

Sustained High Expression of
ID2 Is
Elevated SOCS3, CXCR5, TCF1, and BIM in ID2-Deficient NK Cells A number of genes were found to be upregulated after ID2 deletion in vitro, and aberrant expression of several of these might result in the observed block in peripheral NK cell homeostasis in vivo. Immunoblotting for SOCS3 demonstrated that whereas SOCS3 was barely detectable in Id2 +/+ NK cells, SOCS3 protein was clearly evident in NK cells that lacked ID2, confirming the elevated Socs3 expression ( Figure 5A ). Both the long and extra-long isoforms of the pro-apoptotic protein BIM (encoded by Bcl2l11) were also increased in Id2 D/D NK cells compared to ID2-expressing NK cells ( Figure 5A ). Figure 6A ). IL-15 and ID2 are both essential for NK cell development and our data thus far indicate that these pathways are interrelated. We also noted that Id2 expression was augmented in NK cells over time after IL-15 stimulation ( Figures 6B and 6C ). In Id2 D/D NK cells, the inability to augment
Id2 expression in response to IL-15 coincided with a large increase in Socs3, Bcl2l11, and Tcf7 at 6 hr, reinforcing the ongoing requirement for ID2 to silence E-protein target gene expression in NK cells ( Figure 6C ). To further explore this, we investigated Socs3 and Tcf7 expression during normal NK cell maturation because Id2 expression (Id2-GFP) was found to increase with NK cell differentiation ( Figure 1B) . Indeed, we observed that as Id2 expression increased from immature (Imm.) through mature 1 (M1) to mature 2 (M2) stages of NK cell development (Huntington et al., 2007b) , we observed a clear decrease in Socs3 and Tcf7 ( Figure 6D) has not previously been implicated in NK cell developmental defects. Our RNA-seq data indicate that with the exception of Socs3 and Tcf7, these Id2-suppressed genes are not expressed in in vitro derived control NK cells (Figure 4) . Mature ex vivo NK cells displayed a similar expression pattern with the exception of some Hes1 expression ( Figure 6E ) and this is also true of total splenic NK cells (Bezman et al., 2012) . Deletion of Socs3 in hematopoietic cells alone or specifically in NK cells ( Figures 7A and S2A ) had no effect on NK cell homeostasis whereas germline deletion of Tcf7 did not affect peripheral NK cell development but did skew the inhibitory receptor repertoire (Held et al., 1999) . Given the clear block in IL-15 signaling, we focused our attention on Socs3 (suppressor of cytokine signaling 3). We hypothesized that although Socs3 is not highly expressed in control NK cells and not significantly induced by IL-15 stimulation in control NK cells ( Figure 6B) 
Id2
+/+ mice were injected on days 0, 2, and 4 with IL-2 pre-ligated to anti-IL-2 antibody (clone S4B6) (Boyman et al., 2006; Prlic et al., 2007) or PBS and lymphoid organs analyzed on day 6. In line with our hypothesis, we observed that Id2 was not required Figure 7D ). The NK cells generated after IL-2 treatment of Id2 fl/fl Ncr1 iCre/+ mice were indeed NKp46 + (Figure 7E ), indicating that Cre was expressed, and qPCR analysis of sorted mature NK cells (Mac-1 + ) from these mice failed to detect Id2 (Idb2) transcripts, confirming Id2 deletion ( Figure 7F ). Id2 D/D NK cells generated after IL-2 treatment maintained their high expression of Tcf7 and Socs3, indicating that restoration of IL-15 receptor signaling in vivo was not due to reversal of aberrant E-protein target gene expression ( Figure 7F) can still impair IL-15 receptor signaling in the presence of super-physiological IL-15 ligands ( Figure S5 ). Taken together, these data confirm the link between ID2 and IL-15 signaling and reveal that the role for ID2 in maintaining NK cell fate can be bypassed in vivo by super-physiological stimulation of the IL-15 receptor.
DISCUSSION
ID2 is essential for innate lymphocyte development and has long been regarded as the key transcriptional regulator of NK cell fate. We have demonstrated here for the first time that this strict dependence on ID2 activity is in part due to its role in maintaining NK cell responsiveness to physiological concentrations of IL-15. Despite Il15
, and Id2 À/À mice displaying a similar arrest in bone marrow NK cell development, a link between these pathways has not previously been made (Boos et al., 2007; Kennedy et al., 2000; Lodolce et al., 1998; Yokota et al., 1999) . We have demonstrated unequivocally that deletion of Id2 is incongruous with mature NK cell homeostasis. Inducible deletion of Id2 in all hematopoietic cells (ERT2-cre) and conditional deletion of Id2 specifically in NK cells (Ncr1-icre) resulted in the rapid loss of NK cells from the periphery of mice, highlighting the ongoing requirement for ID2 in suppressing E-protein target gene expression at all stages of NK cell ontogeny. These results support a recent study where deletion of Id2 in ILC3s (Rorc-cre) also results in their loss from tissues (Guo et al., 2015) and suggests that re-expression or elevated expression of E-protein target genes in all ID2-dependent ILCs is detrimental to their maintenance. RNA-seq data from the Id2-null ILC3 have not been performed and it will be key to investigate whether ILC3 responsiveness to the homeostatic cytokine IL-7 is perturbed and analogous to the impaired IL-15 signaling in Id2-null NK cells. ID2 expression is consistently high throughout all stages of NK cell development, so genes found to be repressed by ID2 in our transcriptomic analysis of mature Id2 D/D NK cells are probably repressed earlier during NK cell developmental. Many of the ID2-repressed genes identified in NK cells are transcription factors and receptors required for normal T cell development (Tcf7, Hes1, Idb3, Cd3g, Cd3d, Trgv2, Trvb15, and Tcrg) , with many of these genes being lowly expressed in NK cells. In contrast, genes required for normal B cell development (Pax5, Ebf1, Btk, Blnk, CD19, CD79a) were not found to be repressed by ID2 because most of these genes were not expressed in NK cells. This result suggests that lymphoid progenitors committing to the NK cell lineage might still retain T cell but not B cell potential and that ID2 might be required to block T cell fate in NK cell progenitors. We could not test T cell potential from mature Id2-null NK cells in vitro using the OP9-DL1+L-7 culture system or by in vivo transplantation due to inability to maintain viable Id2-null NK cell in these setting. It would be interesting to test whether deletion of Id2 in the pre-pro NK cell or NKP restored or increased T cell potential. Along these lines, RNA-seq data from normal Imm., M1, and M2 NK cell subsets revealed that the expression pattern of ID2-repressed genes and Id2 were inversed. Immature NK cells expressed lower Id2 and higher ID2-repressed genes, notably Tcf7, Socs3, Idb3, Cd3g, and Cd3d, compared to M2 NK cells where ID2 expression was higher. This was confirmed by qPCR and offers physiological relevance to our in vitro findings and indicates that E-protein target genes are indeed differentially expressed during NK cell development. This finding suggests an ongoing role for ID2 in innate lymphopoiesis by titrating E-protein gene expression through development, maturation, and effector function.
In mature NK cells, we confirmed that ID2 was required to antagonize the expression of a number of E-box genes including Socs3, Cxcr5, Hes1, Tcf7, Il10 , and Idb3 and that elevated expression of these genes compromises IL-15 receptor signaling. Exactly which E-proteins are driving the expression of these E-box genes after Id2 deletion remains to be tested. Multiple E-protein genes (Tcf12, Tcf4, and Tcf3) are expressed in mature NK cells and there is probably some overlap in the function of the encoded proteins. Indeed, germline deletion of Tcf3 in Id2 À/À mice failed to restore the development of peripheral NK cells (Boos et al., 2007) , suggesting that E-box genes are still elevated. We found NK cells to present a very similar list of differentially expressed genes after ID2 deletion compared to mature T cells. ID2-deficient T cells also express elevated Tcf7, Bcl2l11, Socs3, Cxcr5, Idb3, Il10 , and reduced Klrg1 expression, with this impacting on the antigen-specific T cells but not overall T cell development and homeostasis (Lin et al., 2012; Masson et al., 2013 Masson et al., , 2014 . Impaired IL-15 signaling after Id2 deletion results in a loss of NK cells in vivo in part due to accelerated BIM-dependent NK cell apoptosis. Consistently, deletion of Id2 in NKT cells culminates in impaired NKT cell survival and reduced BCL2 and BCLXL expression (Monticelli et al., 2009) , whereas ID2 deletion in CD4 + T cells elevates Bcl2l11 expression, resulting in enhanced apoptosis of antigen-specific CD4 + T cells (Lin et al., 2012) . Although it is possible that the impaired homeostatic proliferation we report also contributes to NK cell lymphopenia, it is unlikely because NK cell turnover is very low in lymphoid-sufficient mice (Huntington et al., 2007b; Prlic et al., 2003) . Furthermore, NK cell survival and proliferation are outcomes that differ based on IL-15 concentrations. As illustrated in this study and evident in several others (Carson et al., 1994; Huntington et al., 2007a Huntington et al., , 2007b Prlic et al., 2003; Zheng et al., 2008) and Id2 À/À mice lack all ILCs (Geiger et al., 2014; Seillet et al., 2014b; Yokota et al., 1999; Yu et al., 2014) , we propose a layered requirement for these factors in driving NK cell fate, with Nfil3 being essential for commitment and Id2 being essential for their maintenance. This requirement for Id2 expression to maintain NK cell fate and the ability to bypass this dependency by increasing IL-15 receptor signaling shifts the paradigm from Id2 acting to simply block alternate cell fates (DCs, B cells, or T cells) during lymphocyte commitment in lymphoid progenitors. Instead, our data reveal a pioneering example of a master regulator of lymphocyte fate that is continually required throughout lineage differentiation for cell survival and proliferation. This observation opens up a field of investigation into the role of E-proteins during NK cell responses, where ID2 and E-proteins might be regulated by inflammation to dictate distinct immunological outcomes.
EXPERIMENTAL PROCEDURES Mice
Rosa26-CreERT2 (TaconicArtemis), Vav1-Cre (de Boer et al., 2003) , Id2-gfp (Jackson et al., 2011) , Id2-loxP (Masson et al., 2013) , Mx-Cre (Kü hn et al., 1995) , Socs3-loxP (Croker et al., 2003) , Ifng
Socs1
À/À (Alexander et al., 1999) , Bcl2l11-loxP (Herold et al., 2014) , and Ncr1-iCre (Narni-Mancinelli et al., 2011) mice were bred and maintained at the Walter and Eliza Hall of Medical Research. All mice were bred and maintained under specific-pathogen-free conditions at the Walter and Eliza Hall Institute animal breeding facility according WEHI and the National Health and Medical Research Council Australia animal ethics. Both female and male mice aged between 4 and 15 weeks of age were used in this study.
In Vivo Treatments
For melanoma metastasis, 5 3 10 4 B16F10 melanoma cells (perforin-sensitive, FasL-and TRAIL-insensitive, H-2 b ; ATCC) were injected i.v. into mice, which were monitored for respiratory difficulty and weight loss. At 12 days, mice were sacrificed. Lymphoid organs, kidney, liver, and lungs were harvested and fixed in Bouin's solution and B16F10 metastases were counted (Gilfillan et al., 2008) . For bone marrow transplants, 1 3 10 7 total bone marrow cells were injected i.v. into lethally irradiated mice (2 3 5.5 Gy). For IL-2 treatment, 1.5 mg IL-2 (Peprotech) and 10 mg anti-IL-2 (S4B6) were incubated together at 37 C for 30 min and then injected i.p. as previously described (Holmes et al., 2014) . Tamoxifen oral gavage was performed as described previously (Glaser et al., 2012; Vikstrom et al., 2010) , and poly(I:C) treatments were performed as described previously in vitro derived NK cells in unbuffered glucose-free DMEM in basal conditions. NK cells were stimulated with glucose (25 mM), oligomycin (1 mM), FCCP (1.5 M) plus pyruvate (1 mM), and antimycin A (1 mM) plus rotenone (0.1 mM) with ECAR and OCR being measured every 7 min for 105 min by an XF-96 Extracellular Flux Analyzer (Seahorse Bioscience).
Cytokine Bead Array 1 3 10 5 NK cells were cultured in 96-well plates for 36 hr in 50 ng.mL À1 IL-15, 100 ng.mL À1 IL-18, and 2 ng.mL À1 IL-12 (Peprotech). Supernatants were the collected and assayed for cytokines using the Bio-Rad Bioplex cytokine bead assay (Mouse 23-Plex Panel).
Quantitative PCR and RNA-Seq Total RNA from NK cells was purified with RNeasy mini columns (QIAGEN). SuperScript II reverse transcriptase (Roche) was used for first-strand cDNA synthesis according to the manufacturer's instructions. Quantitative PCR was performed with Sensimix SYBR HI-ROX (Bioline) and the Bio Rad CFX384 detection system and software (Bio Rad). Primers used (Idb2 [Id2] , Tcf7, Tbx21, Socs3, Socs1, Nfil3, Prdm1 , and Ikzf2) have been described (Holmes et al., 2014; Masson et al., 2013 Masson et al., , 2014 Seillet et al., 2014a; Wormald et al., 2006) . The relative expression of each gene was normalized to Hprt. Paired-end RNA sequencing is described in the Supplemental Experimental Procedures.
Statistical Analysis
A standard Student's t test with two-tailed distributions for two-samples with equal variance was used for statistical analysis. p values are provided. These tests were run on Prism software (GraphPad).
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